# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-008572
Filing Date
2020-04-10
Accepted
2020-04-10 11:20:45
Documents
3
Period of Report
2020-05-20
Effectiveness Date
2020-04-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | nc10009461x1_def14a.htm | DEF 14A | 756280
2 |  | nc10009461x1_pc01.jpg | GRAPHIC | 1358122
3 |  | nc10009461x1_pc02.jpg | GRAPHIC | 1335868
| Complete submission text file | 0001140361-20-008572.txt |  | 4275768

Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 20786212
SIC: 2834 Pharmaceutical Preparations